Synthesis and Antiviral Activity of New Anti-HIV Amprenavir Bioisosteres

Luc Rocheblave, Frédéric Bihel, C. De Michelis, Ghislaine Priem, Jérôme Courcambeck, Brice Bonnet, Jean‐Claude Chermann, Jean‐Louis Kraus

Journal of Medicinal Chemistry · 2002 · 19 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

Starting from the chemical structure of the recent FDA-approved anti-HIV drug Amprenavir (Agenerase), a potent HIV-protease inhibitor, we have designed new series of Amprenavir bioisoteres in which the methylene group of the benzyl group was replaced by a sulfur atom. This structural modification has required an original multistep synthesis. Unfortunately, introduction of the sulfur atom abolished or drastically decreased both inhibitory activity on recombinant HIV protease and HIV infection protection on MT4 cell cultures.

References

18